Abstract
E- and P-selectin are inflammation-induced cell adhesion molecules that mediate leukocyte-endothelial cell and leukocyte-platelet interactions. Monoclonal antibodies (MoAbs) specific for either E-selectin or P-selectin are protective in several animal models of inflammatory disease. To generate an MoAb with broader therapeutic potential, MoAbs that bind to both E- and P-selectin were generated by immunization of mice with mouse pre-B cell lines transfected with human E- and P-selectin. Interestingly, although the only selection criterion was the ability to bind both E- and P-selectin, all three antibodies obtained efficiently block both E- and P-selectin-mediated functions. The inhibited functions include neutrophil or HL-60 cell binding to tumor necrosis factor-α-activated human umbilical vein endothelial cells, E- or P-selectin transfectant cell lines, and platelet-HL-60 resetting. These antibodies, EP-5C7, EP-2C9, and EP-1D8, recognize the same or overlapping epitope within the lectin domains of E- and P-selectin. The data suggest that functionally important epitopes of homologous proteins can be targeted by selecting for antibodies with reactivity toward both proteins. Furthermore, a potent blocking antibody specific for both E- and P-selectin may provide a more effective and broadly useful reagent for treating acute and potentially certain chronic inflammatory conditions. © 1995 by The American Society of Hematology.
Cite
CITATION STYLE
Berg, E. L., Fromm, C., Melrose, J., & Tsurushita, N. (1995). Antibodies Cross-Reactive with E- and P-Selectin Block Both E- and P-Selectin Functions. Blood, 85(1), 31–37. https://doi.org/10.1182/blood.v85.1.31.bloodjournal85131
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.